In the future study, we need to obtain evidence on the protective effect of HSA-Trx on other animal models of heart failure such as cardiac ischemia–reperfusion injury and pressure overload-induced heart failure mice to strengthen the applicability of HSA-Trx. Here, TXN is linked to myocardial ischemia.